Biosciences to launch $40M Series A at JPM 2026, advancing CS-0003 mucosal-immune therapies for GI SSI and the GB platform.

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

TECregen seed funding supports the development of thymus regeneration biologics designed to restore immune function and ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

The buyout is a bet by Lilly on an increasingly popular drug target known as NLRP3 inflammasomes, which are implicated in an ...

Jaden Chizuruoke May ’29 worked with teammates Rihanna Arouna ’29 and Marian Akinsoji ’29 to design the chemically powered ...

Sitryx’s clinical pipeline also includes a novel, oral mimetic of the natural anti-inflammatory metabolite itaconate, SYX-1042. A Phase 1 first-in-human study completed successfully in 2025 and the ...

This article originally published at Cheese recalled from H-E-B, Sam's Club poses potentially deadly risk, FDA warns. Are you ...

On January 6, Ambriola Company, a supplier of cheese for Locatelli, Member's Mark, Pinna, and Boar's Head, updated a Class I ...

Certain people risk severe or life-threatening reactions if they consume these products, according to an official alert.

PONTE VEDRA, FL / ACCESS Newswire / December 30, 2025 / Some companies enter a market because they see opportunity. Others step in because the situation has become unsustainable, and someone has to ...

PONTE VEDRA, FL / / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those corners turned ...